Skip to main content

Patricia Bogdanov Baruj

Institutions of which they are part

Postdoctoral researcher
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Patricia Bogdanov Baruj

Institutions of which they are part

Postdoctoral researcher
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Projects

Administración tópica (colirio) de sitagliptina como tratamiento para la retinopatía diabética proliferativa (TopSit@)

IP: Rafael Simó Canonge
Collaborators: Anna Duarri Piqué, Cristina Hernández Pascual, Patricia Bogdanov Baruj
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 128570
Reference: PDC2022-133991-I00
Duration: 01/12/2022 - 30/11/2024

Ministerio de Ciencia

Diabetis i metabolisme

IP: Rafael Simó Canonge
Collaborators: Josep A Villena Delgado, Carles Zafon Llopis, Cristina Hernández Pascual, David Martinez Selva, Rosario Pardo Diaz, Angel Michael Ortiz Zuñiga, Andreea Ciudin Mihai, Fiorella Ximena Palmas Candia, Ana Maria Ortiz de Urbina Olive, Monica Sanchez Bartres, Lorena Ramos Pérez, Marc Rivas Agudo, Anna Deàs Just, Anna Casteras Román, Alejandra Planas Vilaseca, Betina Biagetti Biagetti, Judit Amigó Farran, Mercè Abad Martín, Marta Comas Martínez, Rosa Burgos Peláez, David Sabater Martínez, Olga Simó Servat, Patricia Bogdanov Baruj, Maria Llorian Salvador, Enzamaría Fidilio Meli
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 60000
Reference: 2021 SGR 00655
Duration: 01/01/2022 - 30/06/2025

Hemopexin: un nuevo factor patogénico en las complicaciones microvasculares de la diabetes.

IP: Cristina Hernández Pascual
Collaborators: Marina Lopez Martinez, Ana Boixadera Espax, Alejandra Planas Vilaseca, Patricia Bogdanov Baruj, Pilar Costa Forner
Funding agency: Instituto de Salud Carlos III
Funding: 139150
Reference: PI22/01670
Duration: 01/01/2023 - 31/12/2025

Bloqueo intraocular de la hemopexina: una nueva estrategia para tratar el edema macular diabético

IP: Rafael Simó Canonge
Collaborators: Patricia Bogdanov Baruj
Funding agency: Instituto de Salud Carlos III
Funding: 78100
Reference: DTS19/00171
Duration: 01/01/2020 - 31/12/2021

Related news

The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.

This investment from EIT Health in the project will enable D-Sight to progress in the clinical development of its groundbreaking treatment for the early stages of diabetic retinopathy.

This initiative of the ”la Caixa” Foundation offers the selected entrepreneurial scientists financial support and support through individual mentoring and training.

Related professionals

Gemma  Duarri Llado

Gemma Duarri Llado

Predoctoral researcher
Reconstructive Surgery of the Locomotor System
Read more
Jordi Masiá Gridilla

Jordi Masiá Gridilla

Predoctoral researcher
New Technologies and Craniofacial Microsurgery
Read more
Eduard  Argudo Serra

Eduard Argudo Serra

Predoctoral researcher
Shock, Organ Dysfunction and Resuscitation
Read more
Anna Enrich  Font

Anna Enrich Font

Research technician
Clinical Research/Innovation in Pneumonia & Sepsis (CRIPS)
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.